Clinical Trial Update: Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing XTR004 PET and MIBI SPECT in borderline coronary stenosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• Technetium-99m sestamibi (Technetium-99m sestamibi)
• XTR004

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Myocardial Perfusion Imaging, Diagnostic Certainty | Phase 2 | Status: TERMINATED